Targeted quantitative lipidomics studies confirmed a pathogenic role for variants in genes associated with lipid metabolism disorders, such as PI4KA [38], PCYT2 [40] and ACER3, in n = 4 cases. This evidence concerns the gene PI4KA and Disorder of lipid metabolism.